Detalles de la búsqueda
1.
Sustained clinical remission for 5 years in severe epidermolysis bullosa acquisita following rituximab infusions.
J Eur Acad Dermatol Venereol
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357844
2.
Tildrakizumab for the treatment of hidradenitis suppurativa in patients previously treated with adalimumab: a 30-month experience.
Clin Exp Dermatol
; 48(11): 1266-1269, 2023 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434310
3.
Dapsone for the management of severe epidermolysis bullosa simplex: A case report and evidence for a repurposing trial.
J Eur Acad Dermatol Venereol
; 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059700
4.
Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia.
Front Med (Lausanne)
; 10: 1149742, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999066
Resultados
1 -
4
de 4
1
Próxima >
>>